Company Filing History:
Years Active: 2009
Title: Michael Longenecker: Innovator in Synthetic Lipid-A Analog Research
Introduction
Michael Longenecker is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of synthetic lipid research, particularly through his innovative work on Lipid-A analogs. His research has implications for therapeutic applications, showcasing the potential of synthetic components in medicine.
Latest Patents
Michael Longenecker holds a patent for "Synthetic lipid-a-analogs and uses thereof." This invention involves the design and preparation of new synthetic Lipid-A analogs based on monosaccharide and disaccharide derivatives. The structures incorporate novel lipid components that are not found in nature. Additionally, the patent describes liposome formulations containing entirely synthetic components, including synthetic Lipid-A and synthetic lipopeptide derived from tumor-associated MUC1 mucin. The patent also includes comparative test results of the immunostimulating properties and toxicity of the Lipid-A analogs.
Career Highlights
Throughout his career, Michael Longenecker has worked with several prominent companies, including Biomira, Inc. and Oncothyreon Inc. His experience in these organizations has contributed to his expertise in the field of synthetic lipids and their applications in therapeutic settings.
Collaborations
Michael has collaborated with notable colleagues such as Zi-Hua Jiang and Mimi Bach. These collaborations have likely enriched his research and contributed to the advancements in synthetic lipid technology.
Conclusion
Michael Longenecker's work in synthetic lipid research exemplifies the innovative spirit of modern inventors. His contributions have the potential to impact therapeutic applications significantly.